{
    "cik": "19617",
    "company": "JPMORGAN CHASE & CO",
    "filing_type": "10-Q",
    "filing_date": "2022-08-03",
    "period_of_report": "2022-06-30",
    "sic": "6021",
    "state_of_inc": "DE",
    "state_location": "NY",
    "fiscal_year_end": "1231",
    "filing_html_index": "https://www.sec.gov/Archives/edgar/data/19617/0000019617-22-000422-index.html",
    "htm_filing_link": "https://www.sec.gov/Archives/edgar/data/19617/000001961722000422/jpm-20220630.htm",
    "complete_text_filing_link": "https://www.sec.gov/Archives/edgar/data/19617/0000019617-22-000422.txt",
    "filename": "19617_10Q_2022_0000019617-22-000422.htm",
    "content": "Item 1. Financial Statements.\nConsolidated Financial Statements - JPMorgan Chase & Co.:\nConsolidated statements of income (unaudited) for the three and six months ended June 30, 2022 and 2021\nConsolidated statements of comprehensive income (unaudited) for the three and six months ended June 30, 2022 and 2021\nConsolidated balance sheets (unaudited) at June 30, 2022 and December 31, 2021\nConsolidated statements of changes in stockholders equity (unaudited) for the three and six months ended June 30, 2022 and 2021\nConsolidated statements of cash flows (unaudited) for the six months ended June 30, 2022 and 2021\nNotes to Consolidated Financial Statements (unaudited)\nReport of Independent Registered Public Accounting Firm\nConsolidated Average Balance Sheets, Interest and Rates (unaudited) for the three months ended June 30, 2022 and 2021\nGlossary of Terms and Acronyms and Line of Business Metrics\nItem 2. Managements Discussion and Analysis of Financial Condition and Results of Operations.\nConsolidated Financial Highlights\nIntroduction\nExecutive Overview\nConsolidated Results of Operations\nConsolidated Balance Sheets and Cash Flows Analysis\nExplanation and Reconciliation of the Firms Use of Non-GAAP Financial Measures\nBusiness Segment Results\nFirmwide Risk Management\nCapital Risk Management\nLiquidity Risk Management\nConsumer Credit Portfolio\nWholesale Credit Portfolio\nInvestment Portfolio Risk Management\nMarket Risk Management\nCountry Risk Management\nOperational Risk Management\nCritical Accounting Estimates Used by the Firm\nAccounting and Reporting Developments\nForward-Looking Statements\nItem 3. Quantitative and Qualitative Disclosures About Market Risk.\nItem 4. Controls and Procedures.\nPart II - Other information\nItem 1. Legal Proceedings. Item 1A. Risk Factors.\nRefer to Part I, Item 1A: Risk Factors on pages 9-33 of JPMorgan Chases 2021 Form 10-K and Forward-Looking Statements on page 87 of this Form 10-Q for a discussion of certain risk factors affecting the Firm.\nSupervision and regulation\nRefer to the Supervision and regulation section on pages 4-8 of JPMorgan Chases 2021 Form 10-K for information on Supervision and Regulation.  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\nThe Firm did not have any unregistered sale of equity securities during the three months ended June 30, 2022.\nRepurchases under the common share repurchase program\nRefer to Capital Risk Management on pages 44-49 of this Form 10-Q and pages 86-96 of JPMorgan Chases 2021 Form 10-K for information regarding repurchases under the Firms common share repurchase program.\nThrough April 30, 2022, the Firm was authorized to repurchase up to $30 billion of common shares under its previously approved common share repurchase program, that was announced on December 18, 2020. Effective May 1, 2022, the Firm is authorized to purchase up to $30 billion of common shares under a new equity repurchase program.\nAs a result of the expected increase in the SCB in the fourth quarter of 2022 and GSIB surcharge in the first quarter of 2023, the Firm has temporarily suspended share repurchases.\nShares repurchased pursuant to the common share repurchase program during the six months ended June 30, 2022 were as follows.\nSix months ended June 30, 2022 Total number of shares of common stock repurchased Average price paid per share of common stock(a)\nAggregate purchase price of common stock repurchases\n(in millions)(a)\nDollar value of remaining authorized repurchase\n(in millions)(a)\nFirst quarter 18,106,991 $ 138.04 $ 2,500 $ 9,052\nApril 1,980,026 $ 128.77 $ 255 $ 8,797 (b)\nMay 2,437,519 122.65 299 29,701\nJune 563,502 120.85 68 29,633 (c)\nSecond quarter 4,981,047 $ 124.88 $ 622 $ 29,633 (c)\nYear-to-date 23,088,038 $ 135.20 $ 3,122 $ 29,633 (c)\n(a)Excludes commissions cost.\n(b)The $8.8 billion under the prior Board authorization was canceled when the $30 billion repurchase program was authorized by the Board of Directors effective May 1, 2022.\n(c)Represents the amount remaining under the $30 billion repurchase program. Item 3. Defaults Upon Senior Securities.\nNone. Item 4. Mine Safety Disclosures.\nNot applicable. Item 5. Other Information.\nNone. Item 6. Exhibits.\nExhibit No. Description of Exhibit\n15 Letter re: Unaudited Interim Financial Information.(a)\n22 Subsidiary Guarantors and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22.2 to the Annual Report on Form 10-K of JPMorgan Chase & Co. (File No. 1-5805) for the year ended December 31, 2021.)\n31.1 Certification.(a)\n31.2 Certification.(a)\n32 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.(b)\n101.INS The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.(c)\n101.SCH XBRL Taxonomy Extension Schema Document.(a)\n101.CAL XBRL Taxonomy Extension Calculation Linkbase Document.(a)\n101.DEF XBRL Taxonomy Extension Definition Linkbase Document.(a)\n101.LAB XBRL Taxonomy Extension Label Linkbase Document.(a)\n101.PRE XBRL Taxonomy Extension Presentation Linkbase Document.(a)\n104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).\n(a)Filed herewith.\n(b)Furnished herewith. This exhibit shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that Section. Such exhibit shall not be deemed incorporated into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.\n(c)Pursuant to Rule 405 of Regulation S-T, includes the following financial information included in the Firms Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022, formatted in XBRL (eXtensible Business Reporting Language) interactive data files: (i) the Consolidated statements of income (unaudited) for the three and six months ended June 30, 2022 and 2021, (ii) the Consolidated statements of comprehensive income (unaudited) for the three and six months ended June 30, 2022 and 2021, (iii) the Consolidated balance sheets (unaudited) as of June 30, 2022, and December 31, 2021, (iv) the Consolidated statements of changes in stockholders equity (unaudited) for the three and six months ended June 30, 2022 and 2021, (v) the Consolidated statements of cash flows (unaudited) for the six months ended June 30, 2022 and 2021, and (vi) the Notes to Consolidated Financial Statements (unaudited).\nSIGNATURE\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\nJPMorgan Chase & Co.\n(Registrant)\nBy: /s/ Elena Korablina\nElena Korablina\nManaging Director and Firmwide Controller\n(Principal Accounting Officer)\nDate: August 3, 2022"
}